Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Filings indexed 3,182 across all filing types
Latest filing 2021-05-25 Share Issue/Capital Cha…
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 100% confidence The document is a notification to the stock exchange about the allotment of shares under the company's Employee Stock Option Plan (ESOP). It mentions the increase in issued and paid-up capital due to the allotment of shares. The document is short (1408 characters) and serves as an announcement of a capital change rather than a detailed financial report or analysis. It does not contain financial statements or management discussion. Therefore, it fits the category of Share Issue/Capital Change (SHA).
2021-05-25 English
Disclosure pursuant to Reg 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in respect of allotment of 42494 shares under ESOP.
Share Issue/Capital Change Classification · 100% confidence The document is a short disclosure letter addressed to the stock exchange (BSE Limited) regarding the allotment of shares under the company's Employee Stock Option Plan (ESOP). It mentions the allotment of 42,494 fully paid-up equity shares and the resulting increase in the company's issued and paid-up capital. The document is brief (1367 characters) and serves as an announcement of a capital change due to share allotment. It does not contain financial statements or detailed financial analysis. Therefore, it fits the category of a Share Issue/Capital Change announcement rather than a full financial report or other filing types.
2021-05-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of the Q4 FY2021 earnings conference call for Lupin Limited, dated May 13, 2021, with detailed discussions on quarterly financial results, business performance, and Q&A with analysts. It includes management commentary on sales, EBITDA, tax rates, product launches, and market conditions. The presence of a full transcript of the earnings call, including Q&A, clearly identifies this as a Call Transcript (CT). The document is lengthy (15,000 characters) and contains substantive content, not just an announcement or summary. Therefore, the appropriate classification is Call Transcript (CT).
2021-05-25 English
Lupin Limited Q4 FY2021 Earnings Conference Call Transcript.
Call Transcript Classification · 100% confidence The document is a transcript of the Q4 FY2021 earnings conference call for Lupin Limited, dated May 13, 2021. It includes detailed discussions of quarterly financial results, business performance, management commentary, and a Q&A session with analysts. The text explicitly states it is a transcript of the earnings call, which is a typical format for Call Transcripts (CT). The document contains no standalone financial statements or comprehensive report data that would classify it as an Interim/Quarterly Report (IR) or Annual Report (10-K). It is not an announcement or brief summary but a full transcript of the call, including management remarks and Q&A. Therefore, the correct classification is Call Transcript (CT). The document length (15,000 characters) supports it being a full transcript rather than a short announcement or summary.
2021-05-25 English
Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, in respect of Grant of 1769 stock options under Lupin ESOP.
Share Issue/Capital Change Classification · 95% confidence The document is a disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about the grant of stock options to employees under the Lupin Employees Stock Option Plan 2014. It details the number of options granted and the exercise price. This is an announcement related to share-based compensation and changes in capital structure but does not report financial results or detailed financial data. It is not a full report but a regulatory announcement about share options granted. Therefore, it fits best under Share Issue/Capital Change (SHA) category, which covers announcements regarding new share issues or capital changes such as stock options.
2021-05-19 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 95% confidence The document is a disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about the grant of stock options to employees. It details the number of options granted, the plan name, and exercise price. This is an announcement related to share-based compensation and capital changes, specifically about stock options granted. It is not a full financial report, audit, or earnings release. It is not a report publication announcement or certification. The content fits best under Share Issue/Capital Change (SHA) as it relates to stock options granted, which affect capital structure.
2021-05-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.